SCHEMBL2916134

SCHEMBL2916134

COc1c(C(=O)O)cc(N2C(=O)CCNC2=O)cc1C(C)(C)C

nearest known ligand 0.34

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
HSD17B10 Q99714 1/20 0.33
RARG P13631 1/20 0.32
RXRA P19793 1/20 0.32
PPARG P37231 1/20 0.32
TNFRSF1A P19438 1/20 0.32
MGLL Q99685 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2907825 0.90 ALDH1A1 (0.34) MEN1KMT2AL3MBTL1MGLL
SCHEMBL2914123 0.90 MEN1 (0.33) MEN1KMT2AL3MBTL1
SCHEMBL2907963 0.84 GLRA3 (0.38) MEN1KMT2A
SCHEMBL2913600 0.82 NR1H4 (0.40) MEN1KMT2AL3MBTL1HSD17B10
SCHEMBL2915054 0.82 NR1H4 (0.40) MEN1KMT2AL3MBTL1HSD17B10
SCHEMBL2913384 0.82 NR1H4 (0.40) MEN1KMT2AL3MBTL1HSD17B10
SCHEMBL2909795 0.81 NR1H4 (0.39) MEN1KMT2AL3MBTL1HSD17B10
SCHEMBL2917122 0.80 MAPT (0.42) MEN1KMT2AL3MBTL1HSD17B10
SCHEMBL2910598 0.80 NR1H4 (0.56)
SCHEMBL2910576 0.80 MEN1 (0.35) MEN1KMT2AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2222646-A1 URACIL OR THYMINE DERIVATIVE FOR TREATING HEPATITIS C Abbott Laboratories (US) 2010-09-01 EP disclosed
EP-2203431-A1 ANTI-INFECTIVE PYRIMIDINES AND USES THEREOF Abbott Laboratories (US) 2010-07-07 EP disclosed
WO-2009039134-A1 ANTI-INFECTIVE PYRIMIDINES AND USES THEREOF ABBOTT LABORATORIES (US) 2009-03-26 WO disclosed
WO-2009039127-A1 URACIL OR THYMINE DERIVATIVE FOR TREATING HEPATITIS C ABBOTT LABORATORIES (US) 2009-03-26 WO disclosed